Ewan K A Millar

Author PubWeight™ 18.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int J Cancer 2010 1.89
2 Therapeutic targets in triple negative breast cancer. J Clin Pathol 2013 1.33
3 Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol Biomarkers Prev 2010 1.31
4 Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Res 2008 1.30
5 Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res 2011 1.25
6 c-Myc overexpression and endocrine resistance in breast cancer. J Steroid Biochem Mol Biol 2006 1.22
7 Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers. Breast Cancer Res 2011 1.18
8 β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. Cancer Res 2013 1.08
9 Transcription factor ATF3 links host adaptive response to breast cancer metastasis. J Clin Invest 2013 1.00
10 Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX. Breast Cancer Res 2012 0.98
11 Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer--a potential diagnostic pitfall. Histopathology 2009 0.92
12 High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype. Histopathology 2010 0.92
13 The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression. Breast Cancer Res 2011 0.91
14 Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. FEBS J 2013 0.91
15 Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status. Int J Cancer 2010 0.81
16 Primary renal neuroblastoma in adults. Urology 2013 0.81
17 Molecular assays in breast cancer pathology. Pathology 2011 0.77
18 Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia. Case Rep Dermatol Med 2012 0.75